This may be true - however - the issue lies in the fact that if the FDA wanted the cardiovascular trial to be conducted, then WHY DID THEY NOT DISCLOSE THIS A YEAR AGO. This never came out, ever.
I am not frustrated as I bought in for the first time today. I am not down $$ here. I purchased specifically on a very valid appeal request. I dont care if the FDA approves the appeal, nor do I care if the FDA EVER approves the drug. I purchased based on the fact that even the appeal being filed will pop this 50%, at which time, I will be dumping.
The downside here is about .50 cents max as their cash position is about $1.50-$2.00/share. Its a